Call Options

21 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.77 - $1.04 $101,563 - $137,176
131,900 Added 140.17%
226,000 $174,000
Q2 2024

Aug 15, 2024

BUY
$0.76 - $1.79 $25,916 - $61,039
34,100 Added 56.83%
94,100 $79,000
Q1 2024

May 07, 2024

SELL
$0.37 - $0.72 $113,923 - $221,688
-307,900 Reduced 83.69%
60,000 $42,000
Q4 2023

Feb 14, 2024

SELL
$0.67 - $1.17 $35,443 - $61,892
-52,900 Reduced 12.57%
367,900 $264,000
Q3 2023

Nov 14, 2023

SELL
$0.72 - $1.33 $54,720 - $101,080
-76,000 Reduced 15.3%
420,800 $302,000
Q2 2023

Aug 11, 2023

SELL
$0.98 - $1.49 $380,142 - $577,971
-387,900 Reduced 43.85%
496,800 $591,000
Q1 2023

May 16, 2023

SELL
$1.16 - $6.41 $1.02 Million - $5.65 Million
-881,700 Reduced 49.92%
884,700 $1.03 Million
Q4 2022

Feb 14, 2023

SELL
$4.78 - $15.01 $3.14 Million - $9.87 Million
-657,400 Reduced 27.12%
1,766,400 $9.33 Million
Q3 2022

Nov 14, 2022

BUY
$10.22 - $23.7 $11.5 Million - $26.6 Million
1,122,200 Added 86.22%
2,423,800 $27.9 Million
Q2 2022

Aug 15, 2022

BUY
$4.35 - $15.85 $4.59 Million - $16.7 Million
1,056,100 Added 430.18%
1,301,600 $14.7 Million
Q1 2022

May 16, 2022

BUY
$4.55 - $6.41 $407,225 - $573,695
89,500 Added 57.37%
245,500 $1.19 Million
Q4 2021

Feb 14, 2022

SELL
$5.89 - $9.73 $2.56 Million - $4.23 Million
-435,200 Reduced 73.61%
156,000 $919,000
Q3 2021

Nov 15, 2021

BUY
$6.78 - $9.89 $1.1 Million - $1.6 Million
161,900 Added 37.71%
591,200 $5.04 Million
Q2 2021

Aug 11, 2021

SELL
$7.24 - $11.2 $1.98 Million - $3.06 Million
-272,800 Reduced 38.85%
429,300 $3.46 Million
Q1 2021

May 17, 2021

BUY
$8.05 - $20.78 $2.88 Million - $7.43 Million
357,600 Added 103.8%
702,100 $7.57 Million
Q4 2020

Feb 16, 2021

BUY
$2.36 - $9.99 $701,156 - $2.97 Million
297,100 Added 626.79%
344,500 $2.98 Million
Q3 2020

Nov 16, 2020

SELL
$2.58 - $3.36 $15,222 - $19,824
-5,900 Reduced 11.07%
47,400 $124,000
Q1 2020

May 15, 2020

BUY
$2.58 - $4.58 $137,514 - $244,114
53,300 New
53,300 $174,000
Q3 2019

Nov 14, 2019

SELL
$1.81 - $2.36 $71,314 - $92,984
-39,400 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$1.26 - $2.14 $19,782 - $33,598
15,700 Added 66.24%
39,400 $84,000
Q2 2018

Aug 14, 2018

BUY
$1.64 - $2.29 $38,868 - $54,273
23,700 New
23,700 $48,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.